Abstract:
PROBLEM TO BE SOLVED: To economically produce the objective compound by a method of a two step process comprising a reaction of 4-chloro-butyroyl chloride with N-bromosuccinimide and further the reaction of the product with an amine. SOLUTION: A reaction of 4-Chloro-butyroyl chloride with N- bromosuccinimide is carried out by adding thionyl chloride at first and immediately adding a catalytic amount of hydrogen bromide thereto to provide a compound of formula I. Further, the compound of formula I is reacted with an amine of the formula, R-NH2 (R is H, a lower alkyl, a lower alkoxy, a cycloalkyl, a lower alkenyl, an aryl, a heterocycle, etc.) in non-aqueous medium in the presence of sodium hydroxide or potassium hydroxide, and a phase transfer catalyst to provide a compound of formula II in the method for producing an α-bromolactam derivative. The compound of formula II is useful for production of cephalosporins, cephem, carbacephem or an iso-oxacephem derivative. The method can shorten the processes, and provide the objective compound at a low cost without requiring a reagent causing trouble such as bromine atom.
Abstract:
PROBLEM TO BE SOLVED: To provide a new method for preparing a 4,5-diaminochikimic acid derivative. SOLUTION: The method for preparing a 4,5-diaminoshikimic acid derivative of the general formula I (R1 is a (substituted) alkyl group; R2 is an alkyl group; and R3 and R4 are independently H or a amino group substituted group, excluding both H) comprises multiple processes in which furan is used as a starting material.
Abstract:
The invention is concerned with (S)-l-{[2-(5-Methyl-2-phenyl-oxazol-4-yl)- ethylamino]-acetyl}-pyrrolidine-2-carbonitrile mesylate and crystalline polymorphs of this compound. This compound and its polymorphic forms exhibits superior properties compared to the previously known compounds and can be used as medicament for the treatment of disorders which are associated with DPP-IV.
Abstract:
The invention relates to a process for the preparation of pyrido[2, 1-a] isoquinoline derivatives of the formula (I), weherein R 2 , R 3 and R 4 are as defined in the specification, comprising the steps of: a) catalytic asymmetric hydrogenation of an enamine of the formula (II), wherein R 1 is lower alkyl, in the presence of a transition metal catalyst containing a chiral diphosphane ligand, b) introduction of an amino protecting group Prot and c) amidation of the ester to form an amide of formula (V), wherein R 2 , R 3 , R 4 and Prot are as defined in the specification.
Abstract:
The present invention relates to a novel process for the preparation of pyrido[2,1-a] isoquinoline derivatives of the formula (I) wherein R2, R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy and lower alkenyl, wherein lower alkyl, lower alkoxy and lower alkenyl may optionally be substituted by a group consisting of lower alkoxycarbonyl, aryl and heterocyclyl, and the pharmaceutically acceptable salts thereof. The pyrido[2,1-a] isoquinoline derivatives of the formula (I) are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV.
Abstract:
This invention relates to a process of the preparation of the intermediate (S)-4-fluoromethyl-dihydro-furan-2-one of the formula (see formula I) and with its use for the manufacture of pyrido[2,1-a] isoquinoline derivatives of the formula (see formula II) which are useful for the treatment and / or prophylaxis of diseases which are associated with DPP IV.
Abstract:
This invention relates to a process of the preparation of the novel intermediate (S)-4-fluoromethyl-dihydro-furan-2-one of the formula and with its use for the manufacture of pyrido[2,1-a]isoquinoline derivatives of the formula which are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV.
Abstract:
This invention relates to a process of the preparation of the novel intermediate (S)-4-fluoromethyl-dihydro-furan-2-one of the formula and with its use for the manufacture of pyrido[2,1-a]isoquinoline derivatives of the formula which are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV.
Abstract:
SE REFIERE A UN POLIMORFO DE MESILATO DE (S)-1-{[2-(5-METIL-2-FENIL-OXAZOL-4IL)-ETILAMINO]-ACETIL}-PIRROLIDINA-2-CARBONITRILO CARACTERIZADO POR UN MODELO DE DIFRACCION DE RAYOS X DE MATERIAL EN POLVO QUE TIENE PICOS CARACTERISTICOS EXPRESADOS EN GRADOS 2-THETA DE 5,4; 13,3; 15,0; 17,1; 19,5; 21,1; 21,4; 26,9 Y TIENE UN EXPECTRO DE ABSORCION IR QUE TIENE PICOS CARACTERISTICOS EXPRESADOS EN cm-1 DE 3503 cm-1, 2747 cm-1, 2649 cm-1, 1666 cm-1, ENTRE OTROS. SE REFIERE TAMBIEN A U PROCEDIMIENTO DE PREPARACION Y A UNACOMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ENZIMA DIPEPTIDIL-PEPTIDASA IV (DPP-IV) UTILES EN EL TRATAMIENTO DE DIABETES, INTOLERANCIA A GLUCOSA, OBESIDAD Y SINDROME METABOLICO, ENTRE OTROS
Abstract:
The invention provides a multistep synthesis for the preparation of 4,5-diamino shikimic acid derivatives of formula starting from furan. 4,5-Diamino shikimic acid derivatives are potent inhibitors of viral neuraminidase.